Home › Therapeutic areas › Ophthalmology › Geographic Atrophy
Geographic Atrophy (5 companies)
Companies with an active program in Geographic Atrophy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics | OphthalmologyRespiratory Rare | 1 | Phase 3 | 5 |
| ANNX | Annexon | HematologyNeurology+2 Rare | 1 | Phase 3 | 6 |
| BLTE | Belite Bio | MetabolicOphthalmology Rare | 1 | NDA Submitted | 6 |
| LCTX | Lineage Cell Therapeutics | NeurologyOphthalmology Rare | 1 | Phase 2 | 5 |
| OCGN | Ocugen | Infectious DiseaseOphthalmology Rare | 1 | Phase 3 | 12 |
No companies match.